BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32458028)

  • 1. Differential diagnosis of liver metastases of gastrointestinal stromal tumors from colorectal cancer based on combined tumor biomarker with features of conventional ultrasound and contrast-enhanced ultrasound.
    Yang D; Zhuang B; Wang W; Xie X; Xie X
    Abdom Radiol (NY); 2020 Sep; 45(9):2717-2725. PubMed ID: 32458028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of atypical hepatic hemangioma from liver metastases: Diagnostic performance of a novel type of color contrast enhanced ultrasound.
    Wu XF; Bai XM; Yang W; Sun Y; Wang H; Wu W; Chen MH; Yan K
    World J Gastroenterol; 2020 Mar; 26(9):960-972. PubMed ID: 32206006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
    Lu Q; Zhang XL; Han H; Huang BJ; Ding H; Wang WP
    J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
    Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
    Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasonography improves the diagnostic specificity for gallbladder-confined focal tumors.
    Zhuang B; Li W; Wang W; Lin M; Xu M; Xie X; Lu M; Xie X
    Abdom Radiol (NY); 2018 May; 43(5):1134-1142. PubMed ID: 28765975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence.
    Quaia E; D'Onofrio M; Palumbo A; Rossi S; Bruni S; Cova M
    Eur Radiol; 2006 Jul; 16(7):1599-609. PubMed ID: 16552507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added value of contrast-enhanced ultrasound to conventional ultrasound for characterization of indeterminate soft-tissue tumors.
    Hu Y; Li A; Wu MJ; Ma Q; Mao CL; Peng XJ; Ye XH; Liu BJ; Xu HX
    Br J Radiol; 2023 Jan; 96(1141):20220404. PubMed ID: 36400064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
    Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
    World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary breast lesions detected using conventional ultrasound and contrast-enhanced ultrasound: Imaging characteristics and associations with malignancy.
    Niu RL; Li SY; Wang B; Jiang Y; Liu G; Wang ZL
    Eur J Radiol; 2021 Aug; 141():109788. PubMed ID: 34091133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis between hepatic alveolar echinococcosis and intrahepatic cholangiocarcinoma with conventional ultrasound and contrast-enhanced ultrasound.
    Wa ZC; Du T; Li XF; Xu HQ; Suo-Ang QC; Chen LD; Hu HT; Wang W; Lu MD
    BMC Med Imaging; 2020 Aug; 20(1):101. PubMed ID: 32854653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and Quantitative Contrast-Enhanced Ultrasound Combined with Conventional Ultrasound for Predicting the Malignancy of Soft Tissue Tumors.
    Wu M; Hu Y; Hang J; Peng X; Mao C; Ye X; Li A
    Ultrasound Med Biol; 2022 Feb; 48(2):237-247. PubMed ID: 34782165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin.
    Stiekema A; Boldingh QJ; Korse CM; van der Noort V; Boot H; van Driel WJ; Kenter GG; Lok CA
    Gynecol Oncol; 2015 Mar; 136(3):562-6. PubMed ID: 25560808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound features of histologically proven small (≤20 mm) liver metastases.
    Dong Y; Zhang XL; Mao F; Huang BJ; Si Q; Wang WP
    Scand J Gastroenterol; 2017 Jan; 52(1):23-28. PubMed ID: 27577113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
    Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
    Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.
    Li F; Han J; Han F; Wang JW; Luo RZ; Li AH; Zhou JH
    AJR Am J Roentgenol; 2017 Oct; 209(4):767-774. PubMed ID: 28777653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
    J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.